Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Kena Betancur | Corbis News | Getty ImagesPfizer had a "phenomenal" first quarter — and Wall Street took notice, CEO ...
Tag: Pharmaceuticals
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Zoom In IconArrows pointing outwardsMerck's new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck's new vaccine ...
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial
Empty bottles of Moderna's Covid-19 vaccine.Fred Tanneau | AFP | Getty ImagesModerna on Monday said its combination vaccine that targets ...
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday ...
Alphabet’s new CFO was in the middle of the GLP-1 boom. Now she’s onto generative AI
Alphabet incoming CFO Anat Ashkenazi, who spent 23 years at Eli LillyEli LillyAlphabet's outgoing finance chief, Ruth Porat, spent the ...
Alphabet taps Eli Lilly’s Anat Ashkenazi as new CFO
A view of Google Headquarters in Mountain View, California, United States on April 16, 2024. Tayfun Coskun | Anadolu | Getty ...
Pfizer’s drug for advanced lung cancer shows promising long-term trial results
CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in ...
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
The FDA has approved Moderna's RSV vaccine for older adults.Courtesy: ModernaThe Food and Drug Administration on Friday approved Moderna's vaccine ...
Nifty to hit 26,500 in next 18 months, predicts Emkay Investment Managers
With an expected earnings growth of 15%, domestic brokerage firm Emkay Investment Managers expects Nifty to reach 24,500 by December ...
